Men with prostate cancer face different long-term risks depending on whether they choose surgery or radiation therapy, with surgery linked to higher rates of urinary incontinence and erectile ...
The multicenter StereoBed trial will randomize 284 patients to compare five-fraction stereotactic radiotherapy with standard ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
A phase 3 PROTEUS substudy published in European Urology reports that perioperative apalutamide plus hormone therapy around ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
A procedure using only a single incision measuring about 3.5 cm below the navel, without a separate auxiliary incision, has ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
(Reuters Health) - - In men with localized prostate cancer discovered because they had symptoms or noticed during a work-up for another medical problem, radical prostate surgery leads to an average of ...
TORONTO, March 13, 2026 (GLOBE NEWSWIRE)-- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets AI-powered, ...
Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of apalutamide plus androgen deprivation therapy (ADT), given ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results